/
CNSP
$5.15+$0.14 (+2.79%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$7.3M
1M shares
52-week range
$1.90 – $10.59
37% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-1421994.85
CNS Pharmaceuticals, Inc. Common Stock
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
www.cnspharma.com- Employees
- 8
- IPO / List date
- Nov 8, 2019
- HQ
- HOUSTON, TX
Held by traders on TradeandTell
No one on the platform currently holds CNSP.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CNSP as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-07-22 | 1-for-12reverse |
| 2025-02-21 | 1-for-50reverse |
| 2024-06-05 | 1-for-50reverse |
| 2022-11-29 | 1-for-30reverse |
Recent trades on TradeandTell
No one on the platform has traded CNSP yet.
